This fall and winter, Ontario, Quebec and Nunavut will offer nirsevimab — approved by Health Canada in the spring of 2023 —  to all babies going through their first RSV season.

Respiratory syncytial virus, or RSV, season is just a few months away, but new vaccine options have already arrived for ...

Respiratory syncytial virus, or RSV, season is just a few months away, but new vaccine options have already arrived for ...

Multiple RSV vaccines for adults are rolling out in the months ahead, along with two monoclonal antibody shots to provide ...

The treatment provides protective antibodies to infants. It will be available to all Ontario babies born in 2024 as well as ...

The CDC just released new recommendations for the shot in June 2024, focusing on folks that are 60 or older, who are ...

The new, free vaccine, Beyfortus, will be available to children up to 24 months old through their health care provider or at ...

The 2024-25 respiratory season is underway and for the first time, New Brunswick will offer some seniors immunization against ...

RSV is a common virus that affects the respiratory system primarily amongst infants, young children and older adults. Though ...

In the 2023 to 2024 respiratory syncytial virus (RSV) season, more than half of infants were protected by maternal RSV ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

"The award is from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and it's for $3.4 ...